UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.242

Sortiert nach

Development of innate and adaptive immunity to RSV in young children

Cellular immunology, 2024-05, Vol.399-400, p.104824-104824, Article 104824

2024

Link zum Volltext

Verfügbarkeit prüfen

Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity

Vaccine, 2016-09, Vol.34 (42), p.5114-5124

2016

Link zum Volltext

Verfügbarkeit prüfen

Immunological Lessons from Respiratory Syncytial Virus Vaccine Development

Immunity (Cambridge, Mass.), 2019-09, Vol.51 (3), p.429-442

2019

Link zum Volltext

Verfügbarkeit prüfen

Immunology of bovine respiratory syncytial virus in calves

Molecular immunology, 2015-07, Vol.66 (1), p.48-56

2015

Link zum Volltext

Verfügbarkeit prüfen

Novel antigens for RSV vaccines

Current opinion in immunology, 2015-08, Vol.35, p.30-38

2015

Link zum Volltext

Verfügbarkeit prüfen

A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice

Vaccine, 2017-02, Vol.35 (5), p.757-766

2017

Link zum Volltext

Verfügbarkeit prüfen

Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease

Virology (New York, N.Y.), 2016-07, Vol.494, p.215-224

2016

Link zum Volltext

Verfügbarkeit prüfen

Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants

Vaccine, 2020-01, Vol.38 (2), p.251-257

2020

Link zum Volltext

Verfügbarkeit prüfen

VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice

Vaccine, 2024-05, Vol.42 (15), p.3474-3485

2024

Link zum Volltext

Verfügbarkeit prüfen

Equivalent immunogenicity across three RSVpreF vaccine lots in healthy adults 18–49 years of age: Results of a randomized phase 3 study

Vaccine, 2024-05, Vol.42 (13), p.3172-3179

2024

Link zum Volltext

Verfügbarkeit prüfen

Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses

Immunity (Cambridge, Mass.), 2021-04, Vol.54 (4), p.769-780.e6

2021

Link zum Volltext

Verfügbarkeit prüfen

Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naïve infants

Vaccine, 2020-01, Vol.38 (2), p.101-106

2020

Link zum Volltext

Verfügbarkeit prüfen

A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus

Virology (New York, N.Y.), 2019-08, Vol.534, p.1-13

2019

Link zum Volltext

Verfügbarkeit prüfen

Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV) vaccine development, Geneva, 25–26 April 2016

Vaccine, 2019-11, Vol.37 (50), p.7355-7362

2019

Link zum Volltext

Verfügbarkeit prüfen

Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease

Antiviral research, 2019-08, Vol.168, p.9-17

2019

Link zum Volltext

Verfügbarkeit prüfen

Animal models of respiratory syncytial virus infection

Vaccine, 2017-01, Vol.35 (3), p.469-480

Taylor, Geraldine

2017

Link zum Volltext

Verfügbarkeit prüfen

Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles

Vaccine, 2012-07, Vol.30 (35), p.5206-5214

2012

Link zum Volltext

Verfügbarkeit prüfen

Recombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease

Virology (New York, N.Y.), 2015-02, Vol.476, p.217-225

2015

Link zum Volltext

Verfügbarkeit prüfen

Maternal transfer of RSV immunity in cotton rats vaccinated during pregnancy

Vaccine, 2015-10, Vol.33 (41), p.5371-5379

2015

Link zum Volltext

Verfügbarkeit prüfen

A single intranasal immunization with a subunit vaccine formulation induces higher mucosal IgA production than live respiratory syncytial virus

Virology (New York, N.Y.), 2016-12, Vol.499, p.288-297

2016

Link zum Volltext

Verfügbarkeit prüfen

Potential impact of a maternal vaccine for RSV: A mathematical modelling study

Vaccine, 2017-10, Vol.35 (45), p.6172-6179

2017

Link zum Volltext

Verfügbarkeit prüfen

Chimeric virus-like particles containing a conserved region of the G protein in combination with a single peptide of the M2 protein confer protection against respiratory syncytial virus infection

Antiviral research, 2016-07, Vol.131, p.131-140

2016

Link zum Volltext

Verfügbarkeit prüfen

Enteric helminth-induced type I interferon signaling protects against pulmonary virus infection through interaction with the microbiota

Journal of allergy and clinical immunology, 2017-10, Vol.140 (4), p.1068-1078.e6

2017

Link zum Volltext

Verfügbarkeit prüfen

Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV disease

Antiviral research, 2015-03, Vol.115, p.1-8

2015

Link zum Volltext

Verfügbarkeit prüfen

Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years

Virus research, 2011-12, Vol.162 (1), p.80-99

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.242

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.218)
Mit Volltextzugriff
(1.241)

Publikationsform

Artikel
(1.242)

Sprache

Englisch
(1.241)
Japanisch
(156)
Französisch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.157)
Life Sciences & Biomedicine
(1.155)
Respiratory Syncytial Virus
(873)
Humans
(775)
Immunology
(732)
Animals
(600)
Biological And Medical Sciences
(451)
Female
(443)
Virology
(419)
Medicine, Research & Experimental
(377)
Research & Experimental Medicine
(377)
Respiratory Syncytial Viruses - Immunology
(365)
Respiratory Syncytial Virus Infections - Immunology
(345)
Fundamental And Applied Biological Sciences. Psychology
(343)
Microbiology
(321)
Vaccines
(312)
Viruses
(291)
Infant
(289)
Allergy And Immunology
(283)
Mice
(283)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Vaccine
(385)
Journal Of Allergy And Clinical Immunology
(146)
Journal Of Clinical Virology
(83)
Virology
(69)
The Journal Of Pediatrics
(37)
Veterinary Immunology And Immunopathology
(37)
Virus Research
(33)
Antiviral Research
(31)
The Lancet
(26)
Journal Of Immunological Methods
(23)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Development of innate and adaptive immunity to RSV in young children

Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity

Immunological Lessons from Respiratory Syncytial Virus Vaccine Development

Immunology of bovine respiratory syncytial virus in calves

Novel antigens for RSV vaccines

A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice

Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease

Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants

VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice

Equivalent immunogenicity across three RSVpreF vaccine lots in healthy adults 18–49 years of age: Results of a randomized phase 3 study

Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses

Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naïve infants

A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus

Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV) vaccine development, Geneva, 25–26 April 2016

Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease

Animal models of respiratory syncytial virus infection

Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles

Recombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease

Maternal transfer of RSV immunity in cotton rats vaccinated during pregnancy

A single intranasal immunization with a subunit vaccine formulation induces higher mucosal IgA production than live respiratory syncytial virus

Potential impact of a maternal vaccine for RSV: A mathematical modelling study

Chimeric virus-like particles containing a conserved region of the G protein in combination with a single peptide of the M2 protein confer protection against respiratory syncytial virus infection

Enteric helminth-induced type I interferon signaling protects against pulmonary virus infection through interaction with the microbiota

Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV disease

Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years

Aktive Filter

Suchergebnisse filtern